Teva to market cannabis inhaler; FDA makes quality metrics voluntary
This week, Phispers brings you news on J&J’s plans to acquire Actelion and Teva’s ne
Novartis’ plant shut down creates urgency to find alternatives to Chinese APIs
With Novartis shutting two plants in Germany and one in India by 2016-end, the global reliance on Ch